Search

Respiratory outcome

Authors

Lehtonen L, van Wassenaer-Leemhuis A, Wolke D, Parikka V

© Shutterstock

Target group

Infants born very preterm or those infants with risk factors (see preamble TEG Follow-up & continuing care), parents, and families

User group

Healthcare professionals, neonatal units, hospitals, health services, and follow-up teams

Statement of standard

Respiratory health is evaluated as part of a follow-up care programme.

Rationale

Infants born very preterm or infants with risk factors are at increased risk of respiratory morbidity, especially an obstructive airway disease, as compared to full term infants. (1–3) Respiratory symptoms occur most frequently during the first two years (4) but persist through school age and into adolescence. (5–8) At school age, asthma medication is prescribed in up to one third of children born very preterm. (5,8,9) Respiratory disorders, including wheezing during respiratory infections, has been shown to be the most common reason for rehospitalisation in very preterm infants. (10–12)

Those born smallest or most immature or with more severe pulmonary problems during the first hospitalisation (having a diagnosis of bronchopulmonary dysplasia) are more likely to have later respiratory problems. (7,9,11,13,14) There are no published studies assessing the efficacy of routine lung function tests in the follow-up of very preterm infants. However, knowing the increased risks it is important to provide clinical respiratory surveillance for all high-risk infants to identify those who need more detailed tests or intervention. In particular infants with neonatal bronchopulmonary dysplasia should be followed closely to identify those children needing treatment.

Health promotion is important for this group, in particular, parents and families should avoid passive and active exposure to tobacco smoke and where possible environmental pollution. (6,9,11,15–21) Physical training in childhood is known to improve cardiopulmonary fitness. (22,23).

Benefits

Short-term benefits
N/A

Long-term benefits

  • Improved identification of individuals who require further diagnostic tests or treatment of respiratory conditions (consensus)
  • Reduced risk of rehospitalisations (24)
  • Reduced school absence (25)
  • Reduced number of days of restricted activity (25)
  • Reduced emergency room visits (25)
  • Improved respiratory health (consensus)

 

Components of the standard

Component Grading of evidence Indicator of meeting the standard
For parents and family    
1. Parents and families are informed about and invited by healthcare professionals to attend follow-up programmes including respiratory assessment. (1,2) A (High quality)
B (High quality)
Patient information sheet
       
2. Parents and children get recommendations for healthy life style by healthcare professionals. (1,2) A (High quality) Parent information sheet
       
For healthcare professionals    
3. A unit guideline on follow-up including respiratory care is adhered to by all healthcare professionals. B (High quality) Guideline
       
4. Training on the appropriate referral and treatment for high-risk infants with respiratory disease and about health promotion including cessation of household smoking is attended by all responsible healthcare professionals. (11,15,16,22) A (High quality)
B (High quality)
Training documentation
       
For neonatal unit, hospital, and follow-up team    
5. A unit guideline on follow-up including respiratory care is available and regularly updated. B (High quality) Guideline
       
6. Symptomatic individuals are referred to appropriate paediatric respiratory services for longer term surveillance. B (Moderate quality) Clinical records
       
7. Training on the appropriate referral and treatment for high-risk infants with respiratory disease and about health promotion including cessation of household smoking is ensured. B (High quality) Training documentation
       
For health service    
8. A national guideline on follow-up including respiratory care is available and regularly updated. B (High quality) Guideline
       
9. RSV immunisation is available for infants following neonatal bronchopulmonary dysplasia. (26–28) A (Moderate quality) 
B (Moderate quality)
Audit report, guideline
       

Where to go

Further development Grading of evidence
For parents and family  
N/A  
For healthcare professionals  
N/A  
For neonatal unit, hospital, and follow-up team  
A (High quality)
  • Benchmark and make available respiratory outcomes up to adulthood against similar services. (32)
B (Low quality)
For health service  
  • Increase awareness of adverse effects of tobacco use and environmental pollution on respiratory health. (16–18)
A (High quality)
  • Include follow-up information on an electronic healthcare card.
B (Low quality)
   

Getting started

Initial steps
For parents and family
  • Parents and families are informed by healthcare professionals about the importance of respiratory health, avoiding exposure to tobacco smoke and promoting a healthy lifestyle.
  • Parents are informed by healthcare professionals about potential signs of respiratory problems.
For healthcare professionals
  • Attend training on the appropriate referral and treatment for high-risk infants with respiratory disease and about health promotion including cessation of household smoking.
For neonatal unit, hospital, and follow-up team
  • Develop and implement a unit guideline on follow-up including respiratory care.
  • Develop information material about the need for respiratory assessment as part of follow-up programme and of recommendations for healthy life style for parents.
  • Support healthcare professionals to participate in training on the appropriate referral and treatment for high-risk infants with respiratory disease and about health promotion including cessation of household smoking.
For health service
  • Develop and implement a national guideline on follow-up including respiratory care.
  • Develop ways to keep track of high-risk infants including e-health applications.
 

Sources

  1. Korvenranta E, Lehtonen L, Peltola M, Häkkinen U, Andersson S, Gissler M, et al. Morbidities and hospital resource use during the first 3 years of life among very preterm infants. Pediatrics. 2009 Jul;124(1):128–34.
  2. Greenough A. Long-term respiratory consequences of premature birth at less than 32 weeks of gestation. Early Hum Dev. 2013 Oct;89 Suppl 2:S25-27.
  3. Rusconi F, Gagliardi L. Pregnancy Complications and Wheezing and Asthma in Childhood. Am J Respir Crit Care Med. 2018 Mar 1;197(5):580–8.
  4. Baraldi E, Filippone M, Trevisanuto D, Zanardo V, Zacchello F. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 1997 Jan;155(1):149–55.
  5. Lum S, Kirkby J, Welsh L, Marlow N, Hennessy E, Stocks J. Nature and severity of lung function abnormalities in extremely pre-term children at 11 years of age. Eur Respir J. 2011 May;37(5):1199–207.
  6. Doyle LW, Adams A-M, Robertson C, Ranganathan S, Davis NM, Lee KJ, et al. Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era. Thorax. 2017;72(8):712–9.
  7. Hirata K, Nishihara M, Kimura T, Shiraishi J, Hirano S, Kitajima H, et al. Longitudinal impairment of lung function in school-age children with extremely low birth weights. Pediatr Pulmonol. 2017 Jun;52(6):779–86.
  8. Simpson SJ, Logie KM, O’Dea CA, Banton GL, Murray C, Wilson AC, et al. Altered lung structure and function in mid-childhood survivors of very preterm birth. Thorax. 2017;72(8):702–11.
  9. Broström EB, Thunqvist P, Adenfelt G, Borling E, Katz-Salamon M. Obstructive lung disease in children with mild to severe BPD. Respir Med. 2010 Mar;104(3):362–70.
  10. Gray D, Woodward LJ, Spencer C, Inder TE, Austin NC. Health service utilisation of a regional cohort of very preterm infants over the first 2 years of life. J Paediatr Child Health. 2006 Jun;42(6):377–83.
  11. Hennessy EM, Bracewell MA, Wood N, Wolke D, Costeloe K, Gibson A, et al. Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child. 2008 Dec;93(12):1037–43.
  12. Ralser E, Mueller W, Haberland C, Fink F-M, Gutenberger K-H, Strobl R, et al. Rehospitalization in the first 2 years of life in children born preterm. Acta Paediatr Oslo Nor 1992. 2012 Jan;101(1):e1-5.
  13. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics. 2006 Jul;118(1):108–13.
  14. Vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr. 2014 Jan;164(1):40–45.e4.
  15. Doyle LW, Olinsky A, Faber B, Callanan C. Adverse Effects of Smoking on Respiratory Function in Young Adults Born Weighing Less Than 1000 Grams. Pediatrics. 2003 Sep 1;112(3):565–9.
  16. Svanes C. Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey. Thorax. 2004 Apr 1;59(4):295–302.
  17. Moshammer H, Hoek G, Luttmann-Gibson H, Neuberger MA, Antova T, Gehring U, et al. Parental smoking and lung function in children: an international study. Am J Respir Crit Care Med. 2006 Jun 1;173(11):1255–63.
  18. Jones LL, Hashim A, McKeever T, Cook DG, Britton J, Leonardi-Bee J. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011 Jan 10;12:5.
  19. Shen Y, Wu Y, Chen G, Van Grinsven HJM, Wang X, Gu B, et al. Non-linear increase of respiratory diseases and their costs under severe air pollution. Environ Pollut Barking Essex 1987. 2017 May;224:631–7.
  20. Schvartsman C, Pereira LAA, Braga ALF, Farhat SCL. Seven-day cumulative effects of air pollutants increase respiratory ER visits up to threefold. Pediatr Pulmonol. 2017;52(2):205–12.
  21. Korten I, Ramsey K, Latzin P. Air pollution during pregnancy and lung development in the child. Paediatr Respir Rev. 2017 Jan;21:38–46.
  22. Carson KV, Chandratilleke MG, Picot J, Brinn MP, Esterman AJ, Smith BJ. Physical training for asthma. Cochrane Database Syst Rev. 2013 Sep 30;(9):CD001116.
  23. Eichenberger PA, Diener SN, Kofmehl R, Spengler CM. Effects of exercise training on airway hyperreactivity in asthma: a systematic review and meta-analysis. Sports Med Auckl NZ. 2013 Nov;43(11):1157–70.
  24. Razi CH, Cörüt N, Andıran N. Budesonide reduces hospital admission rates in preschool children with acute wheezing. Pediatr Pulmonol. 2017 Jun;52(6):720–8.
  25. Wolf FM, Guevara JP, Grum CM, Clark NM, Cates CJ. Educational interventions for asthma in children. Cochrane Database Syst Rev. 2003;(1):CD000326.
  26. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531–7.
  27. Checchia PA, Nalysnyk L, Fernandes AW, Mahadevia PJ, Xu Y, Fahrbach K, et al. Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2011 Sep;12(5):580–8.
  28. Homaira N, Rawlinson W, Snelling TL, Jaffe A. Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective. Int J Pediatr. 2014;2014:571609.
  29. Horbar JD, Rogowski J, Plsek PE, Delmore P, Edwards WH, Hocker J, et al. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics. 2001 Jan;107(1):14–22.
  30. Lapcharoensap W, Gage SC, Kan P, Profit J, Shaw GM, Gould JB, et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015 Feb;169(2):e143676.
  31. Lee SK, Aziz K, Singhal N, Cronin CM. The Evidence-based Practice for Improving Quality method has greater impact on improvement of outcomes than dissemination of practice change guidelines and quality improvement training in neonatal intensive care units. Paediatr Child Health. 2015 Feb;20(1):e1-9.
  32. National Neonatal Audit Programme (NNAP) | RCPCH [Internet]. [cited 2018 May 25]. Available from: https://www.rcpch.ac.uk/work-we-do/quality-improvement-patient-safety/national-neonatal-audit-programme-nnap

November 2018 / 1st edition / next revision: 2021

Recommended citation

EFCNI, Lehtonen L, van Wassenaer-Leemhuis A et al., European Standards of Care for Newborn Health: Respiratory outcome. 2018.

For the purpose of evaluation, we would be grateful if you could send us details on your profession and country. This information is optional, anonymous and the data processed will exclusively be used for the aforementioned purpose, in line with Article 6, Para. 1 lit. a GDPR (General Data Protection Regulation).

Thank you for your support!